This episode details three critical biostatistical biases in screening tests: selection bias (due to population demographics), lead time bias (overestimating survival because detection is early but not curative), and length time bias (overestimating survival because only indolent forms are detected).
| Condition | Key Finding | Association | Board Exam Tip |
|---|---|---|---|
| Selection Bias | Higher SES/Education in screened group | Better health habits, better access to care | Always question the baseline population demographics of a study showing dramatic results. |
| Lead Time Bias (LTB) | Apparent increase in survival time | Detection occurs before symptoms; no change in ultimate mortality rate | Remember: LTB only affects apparent survival, not actual survival. |
| Length Time Bias (LTB) | Overestimation of prognosis/survival | Screening intervals miss aggressive forms; detects indolent variants | Think "time" vs. "severity." The disease caught is less severe. |
| Randomized Controlled Trial (RCT) | Gold standard for efficacy testing | Random assignment to minimize confounding variables | If a study claims causality, the mechanism must be RCT-proven. |